Skip to main content
    S

    Surgery Partners Inc (SGRY)

    Official site

    HEALTHCARE • MEDICAL CARE FACILITIES • NASDAQ

    $26.79
    -0.16 (-0.59%)

    Market Cap: $3.53B

    Last updated: Nov 17, 2026 at 11:06 AM ET

    Surgery Partners Inc (SGRY) Stock Forecast

    Updated Nov 17, 2026. Estimates and ratings come from consensus analyst data.

    Analysts expect Surgery Partners (SGRY) to earn $0.37 per share in the fiscal year ending Dec 31, 2026, on revenue of $3.20B. Of 7 analysts, 1 rates the stock Buy or Strong Buy, 6 Hold and 0 Sell or Strong Sell, for a consensus of Hold. For the fiscal year ending Dec 31, 2027, the EPS consensus is $0.18.

    Analyst Ratings

    Scoring Strong Buy as 1 and Strong Sell as 5, the 7 ratings average 2.86, inside the Hold band from 2.5 up to 3.5. Buy and Strong Buy make up 14% of the ratings.

    RatingAnalystsShare
    Strong Buy00.0%
    Buy114.3%
    Hold685.7%
    Sell00.0%
    Strong Sell00.0%
    Consensus
    Hold
    Total analysts
    7

    Price Target

    Analyst price targets are part of paid GNG plans. See plans

    Annual Estimates

    From the first fiscal year below to the second, the EPS consensus falls 51.4% and revenue estimates fall 8.8%.

    Fiscal year ending Dec 31, 2026
    $0.37
    EPS consensus, revenue $3.20B
    Fiscal year ending Dec 31, 2027
    $0.18
    EPS consensus, revenue $2.92B
    Next report
    Mar 1, 2027
    Estimated

    EPS range

    Revenue range

    Fiscal year endingEPS consensusEPS rangeEPS analystsRevenue consensusRevenue rangeRev. analysts
    Dec 31, 2026$0.37$0.37 to $0.371$3.20B$3.14B to $3.39B7
    Dec 31, 2027$0.18$0.03 to $0.375$2.92B$2.72B to $3.57B7

    Quarterly Estimates

    The EPS consensus falls from $0.20 for the quarter ending Dec 31, 2026 to $0.02 for the quarter ending Mar 31, 2027.

    EPS range

    Revenue range

    Quarter endingEPS consensusEPS rangeEPS analystsRevenue consensusRevenue rangeRev. analysts
    Dec 31, 2026$0.20$0.12 to $0.3310$778.95M$656.00M to $972.30M10
    Mar 31, 2027$0.02$0.02 to $0.021$705.97M$672.93M to $739.00M2

    Estimate Revisions

    Across the 3 periods below, the last 30 days brought 1 upward and 0 downward EPS revisions.

    PeriodUp 30 daysDown 30 days
    Fiscal year ending Dec 31, 202600
    Fiscal year ending Dec 31, 202710
    Quarter ending Mar 31, 202700

    EPS Trend

    Over the last 90 days, the EPS consensus for the fiscal year ending Dec 31, 2026 has fallen 24.5% from $0.49.

    PeriodNow7 days ago30 days ago60 days ago90 days agoChange
    Fiscal year ending Dec 31, 2026$0.37$0.36$0.35$0.49$0.49-23.8%
    Fiscal year ending Dec 31, 2027$0.18$0.21$0.28$0.63$0.63-71.0%
    Quarter ending Mar 31, 2027$0.02-$0.02-$0.06$0.00$0.00+455.6%

    Frequently Asked Questions About SGRY

    What is the SGRY stock forecast?

    Consensus analyst estimates put Surgery Partners's EPS at $0.37 for the fiscal year ending Dec 31, 2026, on revenue of $3.20B. The consensus rating from 7 analysts is Hold.

    How do analysts rate SGRY stock?

    Of 7 analysts covering Surgery Partners, 0 rate it Strong Buy, 1 Buy, 6 Hold, 0 Sell and 0 Strong Sell, for a consensus of Hold.

    What EPS do analysts expect from SGRY next year?

    For the fiscal year ending Dec 31, 2026, the consensus EPS estimate is $0.37, with estimates from $0.37 to $0.37 from 1 analyst. For the fiscal year ending Dec 31, 2027, the consensus EPS estimate is $0.18, with estimates from $0.03 to $0.37 from 5 analysts.

    What revenue do analysts expect from Surgery Partners next year?

    For the fiscal year ending Dec 31, 2026, the consensus revenue estimate is $3.20B, with estimates from $3.14B to $3.39B. For the fiscal year ending Dec 31, 2027, the consensus revenue estimate is $2.92B, with estimates from $2.72B to $3.57B.

    How many analysts cover SGRY?

    7 analysts rate Surgery Partners stock, and 1 analyst estimates its EPS for the fiscal year ending Dec 31, 2026.